{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:38:02Z","timestamp":1772998682051,"version":"3.50.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA214114"],"award-info":[{"award-number":["U01CA214114"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00464","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T15:29:05Z","timestamp":1585754945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots"],"prefix":"10.3389","volume":"11","author":[{"given":"Christopher J.","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remwilyn","family":"Dayuha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Whiteaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen C.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda G.","family":"Paulovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gesmar R. S.","family":"Segundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Houn","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00763-0","article-title":"Human inborn errors of immunity: 2019. update on the classification from the international union of immunological societies expert committee","author":"Tangye","year":"2020","journal-title":"J Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy Asthma Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","article-title":"Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007","volume":"34","author":"Kobrynski","year":"2014","journal-title":"J Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","article-title":"Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy","volume":"164","author":"Kaveri","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.iac.2015.07.001","article-title":"Overview of immunodeficiency disorders","volume":"35","author":"Raje","year":"2015","journal-title":"Immunol Allergy Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How i treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980\u20132009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10875-017-0422-6","article-title":"Allogeneic reduced-intensity hematopoietic stem cell transplantation for chronic granulomatous disease: a single-center prospective trial","volume":"37","author":"Parta","year":"2017","journal-title":"J Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fped.2019.00443","article-title":"Autologous stem-cell-based gene therapy for inherited disorders: state of the art and perspectives","volume":"7","author":"Staal","year":"2019","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","article-title":"Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study","volume":"6","author":"Ferrua","year":"2019","journal-title":"Lancet Haematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jama.295.5.508","article-title":"Bone marrow transplantation for severe combined immune deficiency","volume":"295","author":"Grunebaum","year":"2006","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MOH.0000000000000396","article-title":"Long-term observational studies of chronic granulomatous disease","volume":"25","author":"Kanariou","year":"2018","journal-title":"Curr Opin Hematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3389\/fimmu.2018.02756","article-title":"Rapid multiplexed proteomic screening for primary immunodeficiency disorders from dried blood spots","volume":"9","author":"Collins","year":"2018","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1373\/clinchem.2008.111989","article-title":"Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening","volume":"54","author":"deWilde","year":"2008","journal-title":"Clin Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fped.2019.00373","article-title":"Universal newborn screening for Severe Combined Immunodeficiency (SCID)","volume":"7","author":"van der Burg","year":"2019","journal-title":"Front Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jaci.2009.04.007","article-title":"Development of a routine newborn screening protocol for severe combined immunodeficiency","volume":"124","author":"Baker","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/ACI.0b013e32833fd6fe","article-title":"Newborn screening for T-cell deficiency","volume":"10","author":"Chase","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jaci.2012.08.054","article-title":"Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency","volume":"131","author":"la Marca","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jpba.2013.08.044","article-title":"The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry","volume":"88","author":"la Marca","year":"2014","journal-title":"J Pharm Biomed Anal."},{"key":"B24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1126\/scitranslmed.aan3508","article-title":"Epigenetic immune cell counting in human blood samples for immunodiagnostics","volume":"10","author":"Baron","year":"2018","journal-title":"Sci Transl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaci.2014.01.040","article-title":"Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots","volume":"134","author":"la Marca","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/prca.201100096","article-title":"Tryptic peptide screening for primary immunodeficiency disease by LC\/MS-MS","volume":"6","author":"Kerfoot","year":"2012","journal-title":"Proteomics Clin Appl."},{"key":"B27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/acs.jproteome.6b00828","article-title":"Quantification of ATP7B protein in dried blood spots by peptide immuno-SRM as a potential screen for Wilson's disease","volume":"16","author":"Jung","year":"2017","journal-title":"J Proteome Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/pr034086h","article-title":"Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA)","volume":"3","author":"Anderson","year":"2004","journal-title":"J Proteome Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","article-title":"Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins","volume":"5","author":"Anderson","year":"2006","journal-title":"Mol Cell Proteomics."},{"key":"B30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1074\/mcp.M900254-MCP200","article-title":"An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers","volume":"9","author":"Whiteaker","year":"2010","journal-title":"Mol Cell Proteom."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1021\/pr4009404","article-title":"High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays","volume":"13","author":"Whiteaker","year":"2014","journal-title":"J Proteome Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1373\/clinchem.2008.109652","article-title":"Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry","volume":"54","author":"Hoofnagle","year":"2008","journal-title":"Clin Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1373\/clinchem.2015.250563","article-title":"Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays","volume":"62","author":"Hoofnagle","year":"2016","journal-title":"Clin Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"M111","DOI":"10.1074\/mcp.M111.013854","article-title":"Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma","volume":"11","author":"Kuhn","year":"2012","journal-title":"Mol Cell Proteomics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"M111","DOI":"10.1074\/mcp.M111.015347","article-title":"Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry","volume":"11","author":"Whiteaker","year":"2012","journal-title":"Mol Cell Proteom."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1021\/acs.analchem.6b00946","article-title":"Automated microchromatography enables multiplexing of immunoaffinity enrichment of peptides to greater than 150 for targeted MS-based assays","volume":"88","author":"Ippoliti","year":"2016","journal-title":"Anal Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nmeth.2763","article-title":"Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins","volume":"11","author":"Kennedy","year":"2014","journal-title":"Nat Methods."},{"key":"B38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1373\/clinchem.2015.245266","article-title":"First steps toward harmonization of LC-MS\/MS thyroglobulin assays","volume":"62","author":"Netzel","year":"2016","journal-title":"Clin Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fimmu.2016.00314","article-title":"Adenosine deaminase deficiency - more than just an immunodeficiency","volume":"7","author":"Whitmore","year":"2016","journal-title":"Front. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","article-title":"Adenosine deaminase deficiency: a review","volume":"13","author":"Flinn","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","article-title":"Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome","volume":"124","author":"Engelhardt","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B42","first-page":"531","article-title":"Chronic granulomatous disease","volume-title":"NADPH Oxidases. Methods in Molecular Biology, Vol 1982","author":"Roos","year":"2019"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/INF.0000000000000840","article-title":"Chronic granulomatous disease: a large, single-center US experience","volume":"34","author":"Bortoletto","year":"2015","journal-title":"Pediatr Infect Dis J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: a comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann N Y Acad Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","article-title":"Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation","volume":"104","author":"Jin","year":"2004","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine."},{"key":"B47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2141.2001.02905.x","article-title":"Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females","volume":"114","author":"Futatani","year":"2001","journal-title":"Br J Haematol."},{"key":"B48","first-page":"318","article-title":"Principles and practice of screening for disease","volume":"16","author":"Wilson","year":"1968","journal-title":"J R Coll Gen Pract."},{"key":"B49","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics."},{"key":"B50","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.1021\/ac102179j","article-title":"Effect of collision energy optimization on the measurement of peptides by Selected Reaction Monitoring (SRM) mass spectrometry","volume":"82","author":"Maclean","year":"2010","journal-title":"Anal Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2249.2008.03589.x","article-title":"Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model","volume":"152","author":"P\u00e9rez","year":"2008","journal-title":"Clin Exp Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.jaci.2014.03.025","article-title":"Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype","volume":"133","author":"Jing","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/BTT.S3103","article-title":"Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)","volume":"3","author":"Booth","year":"2009","journal-title":"Biologics."},{"key":"B54","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.12167","article-title":"Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia","volume":"160","author":"Fargo","year":"2013","journal-title":"Br J Haematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1203\/00006450-197704000-00741","article-title":"Effect of RBC transfusions on adenosine deaminase (ADA) deficient Severe Combined Immunodeficiency (SCID)","volume":"11","author":"Ochs","year":"1977","journal-title":"Pediatr Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T15:29:12Z","timestamp":1585754952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2020.00464"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00464","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"article-number":"464"}}